Literature DB >> 2137846

Androgen excess in women with acne alone compared with women with acne and/or hirsutism.

P Vexiau1, C Husson, M Chivot, J L Brerault, J Fiet, R Julien, J M Villette, N Hardy, G Cathelineau.   

Abstract

Acne is known to be one of the features of hyperandrogenism. The aim of the present work was to study women with persistent acne and without other evidence of hyperandrogenism, such as hirsutism, alopecia, or irregular menses. Among 87 female patients with acne and/or hirsutism, we defined three groups: group 1 (n = 29), patients having treatment-resistant acne without menstrual disturbance, alopecia, or hirsutism; group 2 (n = 27), patients with acne and hirsutism; and group 3 (n = 31), patients with hirsutism alone. Clinical chemistry criteria for hyperandrogenism were based on elevated values of one or more of the following parameters: plasma testosterone, delta-4-androstenedione, dehydroepiandrosterone, urinary 5 alpha-androstane 3 alpha-17 beta-diol, and 17-ketosteroids (with chromatography). Plasma and urine samples were drawn between the 18th and 25th days of the cycle. Among group 1 patients, we found 25 subjects (86%) with hyperandrogenism, according to these laboratory criteria. The etiologies were: polycystic ovary syndrome (36%), adrenal hypersecretion (40%, of which 12% showed secondary polycystic ovaries), isolated increase in 5 alpha-androstane 3 alpha-17 beta-diol (20%), and hyperandrogenism without diagnosis (4%). The parameters were found to be more elevated in these patients than in a control group of 30 normal volunteer women. In groups 2 and 3, the findings were essentially the same as in group 1, except for increased levels of testosterone and the testosterone/SHBG ratio. Furthermore, it was evident that persistent acne may be an isolated sign of hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137846     DOI: 10.1111/1523-1747.ep12874121

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Adrenal androgen abnormalities in women with late onset and persistent acne.

Authors:  H Aizawa; M Niimura
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

2.  The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne.

Authors:  E Carmina; A J Godwin; F Z Stanczyk; J S Lippman; R A Lobo
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

3.  FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.

Authors:  Alexandra Poinas; Marie Lemoigne; Sarah Le Naour; Jean-Michel Nguyen; Solène Schirr-Bonnans; Valery-Pierre Riche; Florence Vrignaud; Laurent Machet; Jean-Paul Claudel; Marie-Thérèse Leccia; Ewa Hainaut; Nathalie Beneton; Cécile Dert; Aurélie Boisrobert; Laurent Flet; Anne Chiffoleau; Stéphane Corvec; Amir Khammari; Brigitte Dréno
Journal:  Trials       Date:  2020-06-25       Impact factor: 2.279

4.  Serum levels of androgens in acne & their role in acne severity.

Authors:  Usma Iftikhar; Nakhshab Choudhry
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.